查看所有供应商和价格请点击：
| 中文名 | 岩皂甾醇 |
|---|---|
| 英文名 | fucosterol |
| 中文别名 |
墨角藻甾醇
岩藻甾醇 |
| 英文别名 |
trans-24-Ethylidenecholesterol
D5-avenasterol MFCD00037543 FUCOSTEROL Fucosterin trans-Stigmasta-5,24(28)-dien-3b-ol 24-ETHYLIDENCHOLEST-5-ENE-3B-OL |
| 描述 | Fucosterol 是从 E. stolonifera 中分离出来的,具有抗脂肪形成,抗糖尿病和抗癌活性。 Fucosterol 通过调节 PPARα 和 C/EBPα 的表达来调节脂肪形成。 |
|---|---|
| 相关类别 | |
| 靶点 |
PPARα; C/EBPα[1] |
| 体外研究 | 与完全分化的对照脂肪细胞相比,岩藻糖醇(0-50μM；7天)抑制PPARα和C/EBPα的表达[1]。岩藻糖醇对T47D和HT29细胞系具有细胞毒性,IC50值分别为27.94和70.41μg/ml,分别[3]。岩藻糖醇降低细胞HEK293,MCF-7和SiHa细胞增殖,IC50值分别为185.4,43.3和34.0μg/ml[4]。细胞活力测定[1]细胞系：3T3-L1脂肪细胞浓度：0μM；25μM；50μM孵育时间：7天结果：抑制PPARα和C/EBPα表达。 |
| 体内研究 | 岩藻糖醇(口服给药；30mg/kg)导致血清葡萄糖浓度显着降低,并表现出对镜片中山梨糖醇积累的抑制[2]。 |
| 参考文献 |
| 密度 | 0.98 g/cm3 |
|---|---|
| 沸点 | 504.2ºC at 760 mmHg |
| 熔点 | 118-120ºC |
| 分子式 | C29H48O |
| 分子量 | 412.69100 |
| 闪点 | 220.3ºC |
| 精确质量 | 412.37100 |
| PSA | 20.23000 |
| LogP | 7.94490 |
| 外观性状 | 白色粉末 |
| 蒸汽压 | 2.8E-12mmHg at 25°C |
| 折射率 | 1.53 |
| 储存条件 | 2-8°C |
| 分子结构 | 1、 摩尔折射率：128.91 2、 摩尔体积（m3/mol）：416.8 3、 等张比容（90.2K）：1036.9 4、 表面张力（dyne/cm）：38.2 5、 极化率（10-24cm3）：51.10 |
| 计算化学 | 1、 疏水参数计算参考值（XlogP）：8.9 2、 氢键供体数量：1 3、 氢键受体数量：1 4、 可旋转化学键数量：5 5、 拓扑分子极性表面积（TPSA）：20.2 6、 重原子数量：30 7、 表面电荷：0 8、 复杂度：687 9、 同位素原子数量：0 10、 确定原子立构中心数量：8 11、 不确定原子立构中心数量：0 12、 确定化学键立构中心数量：1 13、 不确定化学键立构中心数量：0 14、 共价键单元数量：1 |
| 更多 | 1. 性状：不确定 2. 密度（g/mL,25/4℃）：不确定 3. 相对蒸汽密度（g/mL,空气=1）：不确定 4. 熔点（ºC）：118-120 5. 沸点（ºC,常压）：不确定 6. 沸点（ºC, 5.2kPa）：不确定 7. 折射率：不确定 8. 闪点（ºC）：不确定 9. 比旋光度（º）：D20 -38.4°(chloroform) 10. 自燃点或引燃温度（ºC）：不确定 11. 蒸气压（kPa,25ºC）：不确定 12. 饱和蒸气压（kPa,60ºC）：不确定 13. 燃烧热（KJ/mol）：不确定 14. 临界温度（ºC）：不确定 15. 临界压力（KPa）：不确定 16. 油水（辛醇/水）分配系数的对数值：不确定 17. 爆炸上限（%,V/V）：不确定 18. 爆炸下限（%,V/V）：不确定 19. 溶解性：溶于大多数有机溶剂 |
|
Section1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE Product identifiers Product name: Fucosterol CAS-No.: 17605-67-3 Relevant identified uses of the substance or mixture and uses advised against Identified uses: Laboratory chemicals, Manufacture of substances Section2. HAZARDS IDENTIFICATION Classification of the substance or mixture Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. This substance is not classified as dangerous according to Directive 67/548/EEC. Label elements The product does not need to be labelled in accordance with EC directives or respective national laws. Other hazards - none Section3. COMPOSITION/INFORMATION ON INGREDIENTS Substances : 5,24(28)-Stigmastadien-3β-ol Synonyms 3β-Hydroxy-5,24(28)-stigmastadiene Formula: C29H48O Molecular Weight: 412,69 g/mol Section4. FIRST AID MEASURES Description of first aid measures If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. In case of skin contact Wash off with soap and plenty of water. In case of eye contact Flush eyes with water as a precaution. If swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Most important symptoms and effects, both acute and delayed Some steroids show carcinogenic and teratogenic activity. Indication of any immediate medical attention and special treatment needed no data available Section5. FIREFIGHTING MEASURES Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Special hazards arising from the substance or mixture Carbon oxides Advice for firefighters Wear self contained breathing apparatus for fire fighting if necessary. Further information no data available Section6. ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures Avoid dust formation. Avoid breathing vapors, mist or gas. Environmental precautions Do not let product enter drains. Methods and materials for containment and cleaning up Sweep up and shovel. Keep in suitable, closed containers for disposal. Reference to other sections For disposal see section 13. Section7. HANDLING AND STORAGE Precautions for safe handling Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire protection. Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8 °C Specific end uses no data available Section8. EXPOSURE CONTROLS/PERSONAL PROTECTION Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls General industrial hygiene practice. Personal protective equipment Eye/face protection Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. Body Protection Choose body protection in relation to its type, to the concentration and amount of dangerous substances, and to the specific work-place., The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Section9. PHYSICAL AND CHEMICAL PROPERTIES Information on basic physical and chemical properties a) AppearanceForm: solid b) Odourno data available c) Odour Thresholdno data available d) pHno data available e) Melting point/freezingno data available point f) Initial boiling point and no data available boiling range g) Flash pointno data available h) Evaporation rateno data available i) Flammability (solid, gas) no data available j) Upper/lowerno data available flammability or explosive limits k) Vapour pressureno data available l) Vapour densityno data available m) Relative densityno data available n) Water solubilityno data available o) Partition coefficient: n- no data available octanol/water p) Autoignitionno data available temperature q) Decompositionno data available temperature r) Viscosityno data available s) Explosive propertiesno data available t) Oxidizing propertiesno data available Other safety information no data available Section10. STABILITY AND REACTIVITY Reactivity no data available Chemical stability no data available Possibility of hazardous reactions no data available Conditions to avoid no data available Incompatible materials Strong acids, Strong bases Hazardous decomposition products Other decomposition products - no data available Section11. TOXICOLOGICAL INFORMATION Information on toxicological effects Acute toxicity no data available Skin corrosion/irritation no data available Serious eye damage/eye irritation no data available Respiratory or skin sensitization no data available Germ cell mutagenicity no data available Carcinogenicity Some steroids show carcinogenic and teratogenic activity. IARC:No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. Reproductive toxicity Some steroids show carcinogenic and teratogenic activity. Specific target organ toxicity - single exposure no data available Specific target organ toxicity - repeated exposure no data available Aspiration hazard no data available Potential health effects InhalationMay be harmful if inhaled. May cause respiratory tract irritation. IngestionMay be harmful if swallowed. SkinMay be harmful if absorbed through skin. May cause skin irritation. EyesMay cause eye irritation. Signs and Symptoms of Exposure Some steroids show carcinogenic and teratogenic activity. Additional Information RTECS: Not available Section12. ECOLOGICAL INFORMATION Toxicity no data available Persistence and degradability no data available Bioaccumulative potential no data available Mobility in soil no data available Results of PBT and vPvB assessment no data available Other adverse effects no data available Section13. DISPOSAL CONSIDERATIONS Waste treatment methods Product Offer surplus and non-recyclable solutions to a licensed disposal company. Contaminated packaging Dispose of as unused product. Section14. TRANSPORT INFORMATION UN number ADR/RID: -IMDG: -IATA: - UN proper shipping name ADR/RID: Not dangerous goods IMDG: Not dangerous goods IATA:Not dangerous goods Transport hazard class(es) ADR/RID: -IMDG: -IATA: - Packaging group ADR/RID: -IMDG: -IATA: - Environmental hazards ADR/RID: noIMDG Marine pollutant: noIATA: no Special precautions for user no data available SECTION 15 - REGULATORY INFORMATION N/A SECTION 16 - ADDITIONAL INFORMATION N/A |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |